Literature DB >> 7942410

Deep venous thrombosis in hypereosinophilic syndrome.

O Valente, M A Scarpinella-Bueno.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7942410

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN： 0002-838X            Impact factor:   3.292


× No keyword cloud information.
  3 in total

1.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

2.  Eosinophilia and first-line coagulation testing.

Authors:  Giuseppe Lippi; Martina Montagnana; Gian Luca Salvagno; Massimo Franchini; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-07-10       Impact factor: 2.300

Review 3.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.